Income tax (Tables)
|
12 Months Ended |
Dec. 31, 2025 |
| Income tax |
|
| Schedule of the current and deferred portions of income tax expense included in the consolidated statements of comprehensive income |
| | | | | | | | | For the year ended December 31, | | | 2023 | | 2024 | | 2025 | | | US$ | | US$ | | US$ | | | | | | | | Income (loss) before income tax expense | | | | | | | Singapore operations | | 166,966 | | 257,005 | | 202,988 | Other operations | | 121,011 | | (484,521) | | 13,132 | Total | | 287,977 | | (227,516) | | 216,120 | | | | | | | | Current income tax (expenses) benefit | | | | | | | Singapore operations | | (23,049) | | (23,688) | | (20,022) | Other operations | | (7,615) | | 2,221 | | 3,955 | Total | | (30,664) | | (21,467) | | (16,067) | | | | | | | | Deferred income tax benefit (expenses) | | | | | | | Singapore operations | | 109 | | (602) | | (10,360) | Other operations | | 11,699 | | 8,584 | | 9,998 | Total | | 11,808 | | 7,982 | | (362) | | | | | | | | Income tax (expenses) benefit | | | | | | | Singapore operations | | (22,940) | | (24,290) | | (30,382) | Other operations | | 4,084 | | 10,805 | | 13,953 | Total | | (18,856) | | (13,485) | | (16,429) |
|
| Schedule of the reconciliation of total tax expense computed by applying the respective statutory income tax rate to pre-tax income, group's effective tax rate |
| | | | | | | | 2023 | | 2024 | | | | | | | | Singapore statutory income tax rate (*) | | 17.0 | % | 17.0 | % | % Effect of tax holiday and preferential tax benefit | | (7.0) | % | 16.1 | % | Effect of different tax rates available to different jurisdictions | | (19.5) | % | 4.0 | % | Permanent differences (i) | | 14.9 | % | (26.6) | % | Change in valuation allowance | | 10.1 | % | (26.8) | % | Effect of Super Deduction available to the Group | | (9.0) | % | 10.4 | % | Effective income tax rate | | 6.5 | % | (5.9) | % |
*: As a majority of the Group’s businesses is subject to Singapore corporate tax rate, the reconciliation of tax expenses begins at Singapore statutory income tax rate. (i) Permanent differences mainly arise from expenses not deductible for tax purposes including primarily share-based compensation costs and expenses incurred by subsidiaries and VIEs. In accordance with the updated requirements of ASU No. 2023-09 for the year ended December 31, 2025, a reconciliation between the statutory rate and the Group’s effective tax rate is as follows (in thousands, except percentages): | | | | | | | | For the year ended December 31, | | | | 2025 | | | | Amount | | Percent | | | | US$ | | | | Statutory Rate: | | 36,740 | | 17.0 | % | Foreign Tax Effects | | | | | | British Virgin Islands (“BVI”) | | | | | | Statutory tax rate difference between BVI and Singapore | | (35,451) | | (16.4) | % | Nontaxable or nondeductible items | | 21,420 | | 9.9 | % | Others | | 2,472 | | 1.1 | % | Cayman | | | | | | Statutory tax rate difference between Cayman and Singapore | | (21,123) | | (9.8) | % | Nontaxable or nondeductible items | | 21,420 | | 9.9 | % | PRC | | | | | | Statutory tax rate difference between PRC and Singapore | | 7,729 | | 3.6 | % | Change in valuation allowance | | (7,653) | | (3.5) | % | Nontaxable or nondeductible items | | (6,885) | | (3.2) | % | Others | | (1,335) | | (0.6) | % | Other jurisdictions | | (874) | | (0.4) | % | Effect of cross-border tax laws | | 8,388 | | 3.9 | % | Tax credits | | (21,225) | | (9.8) | % | Change in valuation allowance | | 5,236 | | 2.4 | % | Nontaxable or nondeductible items | | 6,065 | | 2.8 | % | Other Adjustment | | 1,505 | | 0.7 | % | Effective tax expense | | 16,429 | | 7.6 | % |
|
| Schedule of the tax effects of temporary differences that give rise to the deferred tax asset balances |
| | | | | | | December 31, | | | 2024 | | 2025 | | | US$ | | US$ | | | | | | Deferred tax assets: | | | | | Tax loss carried forward | | 235,362 | | 286,103 | Allowance for expected credit loss of receivable, accrued expense and others not currently deductible for tax purposes | | 32,441 | | 34,918 | Deferred revenue | | 1,507 | | 1,430 | Impairment of investment | | 2,922 | | 2,988 | Capitalized research and development expenses | | 15,025 | | 28,051 | Others | | (85) | | — | Valuation allowance (i) | | (272,922) | | (330,844) | Deferred tax assets, net | | 14,250 | | 22,646 | | | | | | Deferred tax liabilities: | | | | | Related to the fair value changes of investments | | 12,015 | | 15,179 | Related to acquired intangible assets | | 38,089 | | 31,324 | Others | | 9,214 | | 21,302 | Deferred tax liabilities | | 59,318 | | 67,805 | Classification in the consolidated balance sheets: | | | | | Deferred tax assets, net | | 2,563 | | 9,782 | Deferred tax liabilities | | 47,631 | | 54,941 |
| (i) | Valuation allowance is provided against deferred tax assets when the Group determines that it is more likely than not that the deferred tax assets will not be utilized in the future. In making such determination, the Group considered factors including future taxable income exclusive of reversing temporary differences and tax loss carry forwards. Valuation allowance was mainly provided for net operating loss carry forwards because it was more likely than not that such deferred tax assets would not be realized based on the Group’s estimate of its future taxable income. If events occur in the future that allow the Group to realize more of its deferred income tax than the presently recorded amounts, an adjustment to the valuation allowances will result in a decrease in tax expense when those events occur. |
|
| Summary of valuation allowance |
| | | | | | | | | For the year ended December 31, | | | 2023 | | 2024 | | 2025 | | | US$ | | US$ | | US$ | | | | | | | | Balance at beginning of the year | | (242,051) | | (224,130) | | (272,922) | Additions | | (31,733) | | (60,805) | | (98,692) | Reversals | | 49,654 | | 12,013 | | 40,770 | Balance at end of the year | | (224,130) | | (272,922) | | (330,844) |
|